Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Transact Technologies (TACT) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Transact Technologies (TACT) over the last 17 years, with Q3 2025 value amounting to $20.0 million.

  • Transact Technologies' Cash & Equivalents rose 7668.17% to $20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.0 million, marking a year-over-year increase of 7668.17%. This contributed to the annual value of $14.4 million for FY2024, which is 1682.49% up from last year.
  • Latest data reveals that Transact Technologies reported Cash & Equivalents of $20.0 million as of Q3 2025, which was up 7668.17% from $17.7 million recorded in Q2 2025.
  • Transact Technologies' Cash & Equivalents' 5-year high stood at $20.0 million during Q3 2025, with a 5-year trough of $3.9 million in Q2 2022.
  • For the 5-year period, Transact Technologies' Cash & Equivalents averaged around $11.9 million, with its median value being $11.3 million (2024).
  • Per our database at Business Quant, Transact Technologies' Cash & Equivalents surged by 187022.18% in 2021 and then tumbled by 6589.13% in 2022.
  • Transact Technologies' Cash & Equivalents (Quarter) stood at $19.5 million in 2021, then plummeted by 59.16% to $7.9 million in 2022, then surged by 55.06% to $12.3 million in 2023, then rose by 16.82% to $14.4 million in 2024, then soared by 39.23% to $20.0 million in 2025.
  • Its Cash & Equivalents was $20.0 million in Q3 2025, compared to $17.7 million in Q2 2025 and $14.2 million in Q1 2025.